Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
CDT Equity Inc. amended Second Amendment to the Merger Agreement with Conduit Pharmaceuticals Limited valued at Amendment to Merger Agreement to extend outside date and modify closing conditions. (effective 2023-05-11).
- Action
- amendment
- Agreement
- merger
- Counterparty
- Conduit Pharmaceuticals Limited
- Value
- Amendment to Merger Agreement to extend outside date and modify closing conditions.
- Effective
- 2023-05-11
Exact text from the filing
On May 11, 2023, the Company, Conduit, and Merger Sub entered into a Second Amendment to the Merger Agreement (the “Second Merger Amendment” and, together with the Original Merger Agreement and the First Merger Amendment, the “Merger Agreement”) to provide for (i) removal of the provision that indicates that no tax opinion would be delivered in connection with the closing of the Conduit Business Combination, (ii) a closing obligation that that the Company either (a) be exempt from the provisions of Rule 419 promulgated under the Securities Act of 1933, as amended, other than through its net tangible assets or (b) have at least $5,000,001 of net tangible assets either immediately prior to or upon consummation of the Conduit Business Combination, and (iii) the extension of the outside date for the closing of the Conduit Business Combination from May 31, 2023, to February 7, 2024.
View on SEC.gov